Campylobacter coli outbreak in men who have sex with men, Quebec, Canada, 2010-2011

Emerging Infectious Diseases

Volumn 19, Issue 5, 2013, Pages 764-767

  Gaudreau, Christiane ^a   Helferty, Melissa ^c,f   Sylvestre, Jean Loup ^c   Allard, Robert ^c,d   Pilon, Pierre A ^a,b   Poisson, Michel ^b   Bekal, Sadjia ^a,e  

^a CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

^c Agence de la sante et des services sociaux de Montreal   (Canada)

^d MCGILL UNIVERSITY   (Canada)

^e INSTITUT NATIONAL DE SANTÉ PUBLIQUE DU QUÉBEC   (Canada)

^f PUBLIC HEALTH AGENCY OF CANADA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BETA LACTAMASE; CEFOTAXIME; CIPROFLOXACIN; ERYTHROMYCIN; NALIDIXIC ACID; TETRACYCLINE;

ADULT; ANTIBIOTIC SENSITIVITY; ARTICLE; CAMPYLOBACTER COLI; CAMPYLOBACTER ENTERITIS; CANADA; CLINICAL ARTICLE; DISK DIFFUSION; EPIDEMIC; GENE SEQUENCE; HUMAN; MALE; MEN WHO HAVE SEX WITH MEN; PHENOTYPE; POLYMERASE CHAIN REACTION; PULSED FIELD GEL ELECTROPHORESIS; QUESTIONNAIRE; RETROSPECTIVE STUDY; SEQUENCE ALIGNMENT; SEXUAL TRANSMISSION;

ANTIMICROBIAL RESISTANCE; BACTERIA; CAMPYLOBACTER COLI; CANADA; EMERGENCE; ENTERIC INFECTIONS; HOMOSEXUALITY; MEN; MEN WHO HAVE SEX WITH MEN; QUEBEC;

ADULT; ANTI-BACTERIAL AGENTS; CAMPYLOBACTER COLI; CAMPYLOBACTER INFECTIONS; CIPROFLOXACIN; COINFECTION; DISEASE OUTBREAKS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ERYTHROMYCIN; HIV; HIV INFECTIONS; HOMOSEXUALITY, MALE; HUMANS; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; QUEBEC; RETROSPECTIVE STUDIES; TETRACYCLINE;

EID: 84876852336     PISSN: 10806040     EISSN: 10806059     Source Type: Journal    
DOI: 10.3201/eid1905.121344     Document Type: Article

References (15)

1. Allos BM, Blaser MJ. Campylobacter jejuni and related species. In: Mandell GL, Bennett JE, Dolin R, editors. Principles and practice of infectious diseases, 7th ed. Philadelphia: Elsevier Churchill Livingston; 2010. p. 2793-2802.
2. Blaser MJ, Engberg J. Clinical aspects of Campylobacter jejuni and Campylobacter coli infections. In: Nachamkin I, Szymanski CM, Blaser MJ, editors. Campylobacter, 3rd ed. Washington (DC): American Society for Microbiology; 2008. p. 99-121.
3. Fitzgerald C, Nachamkin I. Campylobacter and Arcobacter. In: Versalovic J, Carroll KC, Funke G, Jorgensen JH, Landry ML, Warnock DW, editors. Manual of clinical microbiology, 10th ed. Washington (DC): American Society for Microbiology; 2011. p. 885-99.
4. Gallay A, De Valk H, Cournot M, Ladeuil B, Hemery C, Castor C, et al. A large multi-pathogen waterbone community outbreak linked to faecal contamination of a groundwater system, France, 2000. Clin Microbiol Infect. 2006;12:561-70. http://dx.doi.org/10.1111/j.1469-0691.2006.01441.x
5. Wardak S, Sadkowska-Todys M. The first report on Campylobacter coli family outbreak detected in Poland in 2006. Eurosurveill. 2008;13: pii: 8052.
6. Hill JE, Paccagnella A, Law K, Melito PL, Woodward DL, Price L, et al. Identification of Campylobacter spp. and discrimination from Helicobacter and Arcobacter spp. by direct sequencing of PCR-amplified cpn60 sequences and comparison to cpnDB, a chaperonin reference sequence database. J Med Microbiol. 2006;55:393-9. http://dx.doi.org/10.1099/jmm.0.46282-0
7. Hunter SB, Vauterin P, Lambert-Fair MA, Van Duyne MS, Kubota K, Graves L, et al. Establishment of a universal size standard strain for use with the PulseNet standardized pulsed-field gel electrophoresis protocols: converting the national databases to the new size standard. J Clin Microbiol. 2005;43:1045-1050. http://dx.doi.org/10.1128/JCM.43.3.1045-1050.2005
8. Gaudreau C, Girouard Y, Gilbert H, Gagnon J, Bekal S. Comparison of disk diffusion and agar dilution methods for erythromycin, ciprofloxacin and tetracycline susceptibility testing of Campylobacter coli and for tetracycline for Campylobacter jejuni subsp. jejuni. Antimicrob Agents Chemother. 2008;52:4475-4477. http://dx.doi.org/10.1128/AAC.00767-08
9. Lachance N, Gaudreau C, Lamothe F, Turgeon F. Susceptibilities of β-lactamase-positive and -negative strains of Campylobacter coli to β-lactam agents. Antimicrob Agents Chemother. 1993;37:1174-1176. http://dx.doi.org/10.1128/AAC.37.5.1174
10. Clinical and Laboratory Standards Institute. Methods for antimicrobial dilution and disk susceptibility testing for infrequently-isolated or fastidious bacteria: approved guidelines; no. M45-A2, vol. 30, no. 18. Wayne (PA): The Institute; 2010.
11. Centers for Disease Control and Prevention. 2010. National Antimicrobial Resistance Monitoring System-enteric bacteria (NARMS) 2009 annual report [cited 2011 Jun 29]. http://www.cdc.gov/narms/pdf/NARMSAnnualReport2009_508.pdf.
12. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing; 22th informational supplement; no. M100-S22, vol. 32, no. 3. Wayne (PA): The Institute; 2012.
13. Gaudreau C, Michaud S. Cluster of erythromycin- and ciprofloxacin-resistant Campylobacter jejuni subsp. jejuni from 1999 to 2001 in men who have sex with men, Québec, Canada. Clin Infect Dis. 2003;37:131-136. http://dx.doi.org/10.1086/375221
14. Gaudreau C, Bruneau A, Ismaïl J. Outbreak of Shigella flexneri and Shigella sonnei enterocolitis in men who have sex with men, Québec, 1999 to 2001. Can Commun Dis Rep. 2005;31:85-90.
15. Gaudreau C, Ratnayake R, Pilon PA, Gagnon S, Roger M, Levesque S. Ciprofloxacin-resistant Shigella sonnei among men who have sex with men, Canada, 2010. Emerg Infect Dis. 2011;17:1747-1750. http://dx.doi.org/10.3201/eid1709.102034